Businesses Solutions • FinTech (& Financials services) • Retail (& E-Commerce) • A.I. (& Big Data) • HealthTech (& Fitness) • Future Of Work • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Mobility
Description
Partner at Index Ventures
Martin Mignot serves as a Partner at Index Ventures. He also serves as Advisory Board Member at TheFamily. He specialises in SaaS, marketplaces, bitcoin and mobile. He worked on 50+ transactions to date, including Assistly, Auxmoney, BaseCRM, Cloud.com, Codecademy, DimDim, Factual, Farfetch, Flipboard, Funding Circle, Gluster, HouseTrip, Just Eat, Lookout, Nasty Gal, Notonthehighstreet, onefinestay, PeoplePerHour, TrustPilot, Soluto and SoundCloud. He is actively looking after Index's investments in Algolia, Capitaine Train, Drivy, Rad and Swiftkey. Prior to joining Index, Martin was in the TMT team at UBS Investment Bank and cofounded the beauty subscription business Boudoir Prive (acquired by Joliebox/Birchbox) and a student web radio service.
Keith Hamlin
Investing in Software (Web Marketplace Saas..) &b...
New York, U.S.A.
Previous Investments
• Inspiren:
(mid stage)
• Kafene:
• Spur:
(early stage)
• Debtsy:
(early stage)
• Petal:
(early stage)
• Zipdrug:
(early stage)
• LoanStreet Inc.:
(mid stage)
• Phase Change Energy Solutions, Inc.:
(mid stage)
Dr. Adam Goulburn served as Partner at Lux Capital. He serves as Board Member at Eikon Therapeutics, Plexium and Mahana Therapeutics. He serves as Board Member at Drone Racing League. He served as Board member at Kallyope. He is based in the firm's New York headquarters and focuses on broad investment opportunities in healthcare IT, services, mobile health, and therapeutics. He was a Board Member of Authorea, Variant Bio & 3Scan. He has worked extensively with a number of Lux portfolio companies including Kala Pharmaceuticals and Genocea Biosciences. He is also a mentor for healthcare IT incubators Blueprint Health and Healthbox. Before joining Lux, he was a Postdoctoral Fellow of Neuroscience at Weill Cornell Medical College, researching regenerative medicine in association with brain disorders including schizophrenia and Alzheimer's disease. Originally from Australia, he has dual undergraduate degrees in Commerce and Science and subsequently completed his Ph.D. at the Australian Stem Cell Centre, having been chosen as a highly selective Premier Scholar. He has published in numerous peer-reviewed scientific journals. Prior to joining Lux in 2011, he received his Ph.D. in neuroscience from Weill Cornell Medical College. He also serves as Board Member at Vesta Healthcare. He serves as Board Member at Rivet Health and rd. MD. He is a Co-Founder of Cajal Neuroscience.
Mr. Aaron Perman serves as Principal at S3 Ventures. He also served as Chief Executive Officer at Qualia. He is also an Angel Investor. Prior to joining S3, he invested in small-cap publicly traded companies at Western Standard, a long/short equity hedge fund. Earlier in his career, he spent time in the corporate strategy group at Southern California Edison and started a successful small business liquidating computer hardware. He serves as a mentor for the DivInc Accelerator and leads the Emerging Venture Capitalist Association's Austin chapter. He received his BS in International Business from the University of Southern California.
Venrock invests in technology and healthcare. Individual focus areas: Biotechnology, Diagnostics, Genomics, Healthcare IT, Medical Devices. Prefers: category kings + big risk element
Eduardo Saverin
Investing in BioTech • Businesses Solutions ...
San Francisco Bay Are..., U.S.A. - Singapore - Brazil
Previous Investments
• iVideoSmart:
$3500000 (Series A)
• Sugar.fit:
$5000000 (Series A)
• Mswipe Technologies:
$20000000 (Series Unknown)
• Mswipe Technologies:
$31000000 (Series E)
• Mswipe Technologies:
$10000000 (Series D)
• Inspace XR:
$4000000 (Seed)
• Hopscotch:
$20000000 (Series E)
• Hopscotch:
$13000000 (Series C)
• Hopscotch:
$11000000 (Series B)
• CoinDCX:
$140000000 (Series D)
• CoinDCX:
$90000000 (Series C)
• Kopi Kenangan:
$96000000 (Series C)
• Kopi Kenangan:
$210000000 (Series B)
• Yalo:
$50000000 (Series C)
• Yalo:
$15000000 (Series B)
• Antler:
$50000000 (Series Unknown)
• Perx Technologies:
$5000000 (Series B)
• Perx Technologies:
$1000000 (Series A)
• Carro:
$30000000 (Series B)
• Carro:
$60000000 (Series B)
• CXA Group:
$25000000 (Series C)
• Tech in Asia:
$7000000 (Series Unknown)
• Tech in Asia:
$4000000 (Series C)
• INTURN:
$23000000 (Series B)
• 99.co:
$8000000 (Series A)
• 99.co:
$2000000 (Seed)
• Intelligent Video Solutions:
$4000000 (Series A)
• Jumio:
$4000000 (Debt Financing)
• Jumio:
$7000000 (Series A)
• Xfers:
$3000000 (Seed)
• Silvercar:
$28000000 (Series C)
• Silvercar:
$14000000 (Series B)
• RedMart:
$27000000 (Series C)
• RedMart:
$23000000 (Series B)
• RedMart:
$5000000 (Series Unknown)
• RedMart:
(Seed)
• Eat Just:
$90000000 (Series C)
• FlightCar:
$14000000 (Series A)
• Tag (Acquired):
$1000000 (Seed)
• Nitrous:
$7000000 (Series A)
• Nitrous:
$1000000 (Seed)
• ShopSavvy:
$7000000 (Series A)
• Qwiki:
$8000000 (Series A)
• Aporta, Inc.:
(Undisclosed)
• CrowdMob:
(Seed)
Eduardo Saverin
San Francisco Bay Area - Los Angeles, U.S.A. - Singapore - Brazil
Eduardo Saverin is a Co-Founder and serves as Partner at B Capital Group. He is a Co-Founder of Facebook. He also co-founded Velos Partners, a private equity firm based in Los Angeles and serves as its Chairman. He serves on the board of Carro, Connexions Asia and Ninja Van. He also serves as Advisor at Golden Gate Ventures.
Ivan Kaunov
Investing in Software (Web Marketplace Saas..) &b...
Paul Silber serves as Co-Founding Principal at Blu Venture Investors. Silber also serves as Advisor at Evergreen Advisors and Insightin Health. Silber serves as Advisor at Evergreen Advisors and also serves as Board Member at Encore Path. He a native of Baltimore was the founder and President/CEO of In Vitro Technologies, (IVT), a bioscience company that provides products and services to pharmaceutical and biotechnology companies. After relocating to Baltimore in 1991, In Vitro grew from two employees to a staff of 70, including several employees in Europe. The company also expanded its international business to Japan, the U.K., and Germany, while bringing the products of international companies to their North American customers through strategic alliances and distribution relationships.
Founder and Managing Partner of PruVen Capital, an independent venture and growth equity platform in partnership with Prudential Financial as our single LP. Our first fund is a $300M multi stage investment vehicle focused on verticals including Insurtech, Fintech, Proptech, Healthtech and Enterprise IT.
Previously Co-founded and Co-led venture investing at Citi Ventures, focused on Fintech/Fin services (Lending, Wealth Management, Capital Markets), Payments (B2B, B2C, P2P, Cyrpto), Commerce (Marketplaces, loyalty, O2O), Big Data, Analytics, Machine learning & AI and Security.
Led investments for Citi Ventures in:
- Square (NYSE: SQ)
- Jet.com (Acq by Walmart for $3.3B)
- Docusign (NASDAQ: DOCU)
- Honey (Acq by Paypal for $4B)
- Grab Inc.
- Udaan
- Datarobot
- Feedzai
- Homelight
- Scratch
- Immuta
- Anaconda
- Ondot Systems (Acq by FiServ)
- Zum
- Fastpay
- Kinetica
- Chain.com
- Ujet
- Flybits
- Stoic Systems
- Ayasdi
- Platfora (Acq by Workday)
- Jumio
- Pepperdata
- DB Networks
- Datameer
- TradeIt
- LiveNinja (Acq by IDT)
Angel investor/advisor to companies including:
- Zappedy (acq by Groupon); Cardspring (acq by Twitter); CheckR; Robinhood, Gridspace; Vicarious and Ipsy
Specialties: Business Development, Strategic partnerships, Corporate development, M&A, Strategic planning, Social web, Consumer internet, eCommerce, Financial services, Digital Media, Payments, Financial Technologies, Financial Services, Big Data and Analytics
Madhu Yalamarthi
Investing in Businesses Solutions • FinTech ...
, Israel - U.S.A.
Previous Investments
• Bright Health:
$635000000 (Later stage VC)
• BigBasket:
$300000000 (Other)
• Livspace:
$90000000 (Later stage VC)
• Collective Medical Technologies:
$47500000 (Early stage VC)
AboutDeena Shakir is a Partner at Lux Capital, where she invests in transformative technologies improving lives and livelihoods. Her investments span stages and sectors, and include women's and family health (e.g. Maven Clinic, Alife, Summer Health), digital health (SteadyMD, Everly Health, Galileo), software for life sciences (Trial Library, H1, Bluenote), health equity (Waymark, Trial Library), fintech (Ramp) and more. Above all, she seeks out extraordinary, mission-driven founders.
Prior to Lux, Deena was a Partner at GV (formerly Google Ventures), led product partnerships at Google for health, search, and AI/ML, and directed social impact investments at Google.org. Deena also served as a Presidential Management Fellow at The U.S. Department of State under Secretary Clinton, where she helped launch President Obama’s first Global Entrepreneurship Summit.
Deena self-funded her undergraduate degree at Harvard (Social Studies and Near Eastern Languages & Civilizations) and MA at Georgetown through a variety of merit scholarships and side hustles, including co-founding her first company while in college. She is currently a Lecturer in Management at the Stanford Graduate School of Business, a Board Director for the National Venture Capital Association, and a member of Kauffman Fellows, Aspen Finance Fellows, and The Council on Foreign Relations.
Deena is a frequent speaker and commentator and has been featured in print and television on Bloomberg, CNBC and CBS, in print in the Wall Street Journal, Fortune, Forbes, Techcrunch, Marie Claire, STAT, and more, and has delivered keynote addresses at major industry conferences. She was named a "Top 30 Under 40 in Healthcare" by Business Insider and "Top Senior Woman to Watch in Venture Capital" by the Wall Street Journal, "Top 50 in Digital Health" by Rock Health and "40 Under 40" by Fortune Magazine in 2022.
She is also the bestselling author of critically acclaimed children's picture book published by Simon & Schuster, Leena Mo, CEO (released September 2024).
Key investment parameters for Vibranium.VC
1. $40k+ net MRR on US market (with incorporated US entity)
2. Annual revenue growth: 300% & higher (MoM 15%+)
3. Valuation CAP: max $25 Mln
4. Tech focus: IT B2B SaaS, PaaS, Cloud services, (Industry agnostic)
5. Stage: Seed, pre-series A, (no bridge rounds)
6. Company: no more than 3 years old
7. Team: Core expertise in the area, serial entrepreneurs
8. Ambition: Grow to $100M ARR
Not Interested In
Not interested in : Pharma, bio\medtech, crypto, hardware, non IT
How to connect with Angel Investors in the Medical Devices industry?
In the Medical Devices & Hospital Services industry, angel investors such as Esther Dyson, Vinod Khosla, and Steve Jurvetson are highly active. These investors focus on startups offering innovative solutions in medical technology, healthcare devices, and hospital services. Esther Dyson, an entrepreneur and investor, looks for companies that leverage technology to improve healthcare delivery and patient outcomes. Vinod Khosla, founder of Khosla Ventures, invests in medical device startups that have the potential to revolutionize patient care. Steve Jurvetson, a co-founder of Future Ventures, seeks out startups with scalable and impactful medical technology solutions. To connect with these investors, attend medical device conferences, healthcare expos, and networking events such as MedTech Conference, Health 2.0, and HIMSS. Utilize platforms like AngelList and LinkedIn to identify and reach out to potential investors. When pitching, emphasize how your medical device or hospital service solution addresses key challenges, such as improving patient care, enhancing operational efficiency, or reducing costs. Highlight any traction you’ve gained, such as partnerships with healthcare providers, successful clinical trials, or regulatory approvals. Building relationships through initial informal meetings or discussions at industry panels can help establish trust with these investors. Demonstrating the impact of your technology through case studies or clinical results can also add credibility. Personalize your outreach by referencing the investor’s previous investments and explaining how your venture aligns with their interests. Demonstrating a sustainable business model with clear revenue streams, such as product sales, licensing, or service contracts, will further strengthen your pitch. Leveraging endorsements or case studies from healthcare experts can also enhance your credibility.
Case Studies: Successful Funding Rounds with Angel Investors on Angels Partners
Exotic Orange & Angels Partners: Turning Financial Simplicity Into Investment Success
